StockData
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. (SLGL) stock

SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$55.12−1.13 (-2.01%)

Close on Nov 13, 2026Market cap $153.57MP/E –Yield –

Earnings

Sol-Gel Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2025
$17.20M
+218.5% on a year earlier
EPS, Q2 FY2025
$4.17
$0.07 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Sol-Gel Technologies's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2025ended Jun 30, 2025Aug 15, 2025before the open$17.20M+218.5%$4.17Release
Q2 FY2024ended Jun 30, 2024Aug 16, 2024before the open$5.40M+809.1%$0.07Release
Q4 FY2023ended Dec 31, 2023Mar 13, 2024before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 10, 2023before the open$594.00K–$0.22Release
Q2 FY2022ended Jun 30, 2022Aug 4, 2022during market hours–––Release
Q4 FY2021ended Dec 31, 2021Mar 30, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Sol-Gel Technologies has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Sol-Gel Technologies puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Sol-Gel Technologies filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?